BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76
19822 results:

  • 1. Evolving horizons in renal angiomyolipoma: two decades of management strategies and clinical perspectives in a single institutional study.
    Keles A; Iplikci A; Arikan O; Culpan M; Baydili KN; Keser F; Yildirim A
    Aging Male; 2024 Dec; 27(1):2346308. PubMed ID: 38709235
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Contrast-Enhanced Ultrasound as a Diagnostic Procedure in Renal Diseases: A Case Report.
    Sellitto S; Tarantino L; Barone F; Barone N; Perna A; Lucariello A; Guerra G; De Luca A; Filippelli A; Sellitto C
    G Ital Nefrol; 2024 Apr; 41(2):. PubMed ID: 38695227
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Epidemiology, treatment and outcomes of primary renal sarcomas in adult patients.
    Uhlig J; Uhlig A; Deshpande H; Ströbel P; Trojan L; Lotz J; Hurwitz M; Hafez O; Humphrey P; Grünwald V; Kim HS
    Sci Rep; 2024 May; 14(1):10038. PubMed ID: 38693188
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Establishment and validation of a nomogram for predicting overall survival of upper-tract urothelial carcinoma with bone metastasis: a population-based study.
    Hu J; Gu H; Zhang D; Wen M; Yan Z; Song B; Xie C
    BMC Urol; 2024 Apr; 24(1):100. PubMed ID: 38689213
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. HECTD2/TNFAIP1 Axis Regulating the p38/JNK Pathway to Promote an Inflammatory Response in Renal Cell Carcinoma Cells.
    Lv D; Chen Y; Tang L; Tian Y; Ren D; Jian N; Shen T
    In Vivo; 2024; 38(3):1094-1103. PubMed ID: 38688591
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma.
    Rahman SN; Long JB; Westvold SJ; Leapman MS; Spees LP; Hurwitz ME; McManus HD; Gross CP; Wheeler SB; Dinan MA
    JAMA Netw Open; 2024 Apr; 7(4):e248747. PubMed ID: 38687479
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Patient's self-reported quality of life as a prognostic factor in metastatic renal cell carcinoma initially treated with TKI: nomogram proposal.
    Lendínez-Cano G; Vilches-Arenas Á; Congregado-Ruíz B; Medina-López R
    World J Urol; 2024 Apr; 42(1):267. PubMed ID: 38678165
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genetic polymorphisms and clinical parameters associated with renal toxicity in Thai hematologic malignancy patients receiving high dose methotrexate.
    Pitakkitnukun P; Pongpitakmetha T; Suttichet TB; Sukkummee W; Chariyavilaskul P; Polprasert C
    Sci Rep; 2024 Apr; 14(1):9695. PubMed ID: 38678107
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus.
    Scilipoti P; Rosiello G; Larcher A; Fallara G; Cignoli D; Re C; Musso G; Cei F; Tian Z; Karakiewicz PI; Mottrie A; Trevisani F; Raggi D; Necchi A; Bertini R; Salonia A; Briganti A; Montorsi F; Capitanio U
    World J Urol; 2024 Apr; 42(1):264. PubMed ID: 38676733
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The Evolution of Upper Tract Urothelial Carcinoma Management in kidney Recipients.
    Lin KJ; Chen SY; Chiang YJ; Chu SH; Liu KL; Lin CT; Pan PY; Wang HH
    Transplant Proc; 2024 Apr; 56(3):554-556. PubMed ID: 38670734
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Soluble Immune Checkpoint Molecules as Predictors of Efficacy in Immuno-Oncology Combination Therapy in Advanced Renal Cell Carcinoma.
    Ueda K; Uemura K; Ito N; Sakai Y; Ohnishi S; Suekane H; Kurose H; Hiroshige T; Chikui K; Nishihara K; Nakiri M; Suekane S; Ogasawara S; Yano H; Igawa T
    Curr Oncol; 2024 Mar; 31(4):1701-1712. PubMed ID: 38668032
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment.
    Pei F; Tao Z; Lu Q; Fang T; Peng S
    World J Surg Oncol; 2024 Apr; 22(1):110. PubMed ID: 38664770
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Immunocompromised individuals are at increased risk of COVID-19 breakthrough infection, hospitalization, and death in the post-vaccination era: A systematic review.
    Bytyci J; Ying Y; Lee LYW
    Immun Inflamm Dis; 2024 Apr; 12(4):e1259. PubMed ID: 38661301
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Management of Nontraumatic Spontaneous Renal Hemorrhage (Wünderlich Syndrome) through Robotic-Assisted Laparoscopic Nephrectomy: A Case Series.
    Tao B; Zhang H; Zhang G; Liu H; Meng L; Zhu X; Ji X; Jia G; Qi A; Wang C
    Am J Case Rep; 2024 Apr; 25():e942826. PubMed ID: 38659203
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Increased level of serum leucine-rich-alpha-2-glycoprotein 1 in patients with clear cell renal cell carcinoma.
    Nakanishi S; Goya M; Suda T; Yonamine T; Sugawa A; Saito S
    BMC Urol; 2024 Apr; 24(1):94. PubMed ID: 38658967
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Oncological results of repeat partial nephrectomy in patients with recurrence after nephron-sparing procedures].
    Matveev V B; Zhumabaev N K; Komarov M I; Klimov A V; Stilidi I S
    Urologiia; 2024 Mar; (1):86-91. PubMed ID: 38650411
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Biomarker vs MRI-Enhanced Strategies for Prostate Cancer Screening: The STHLM3-MRI Randomized Clinical Trial.
    Björnebo L; Discacciati A; Falagario U; Vigneswaran HT; Jäderling F; Grönberg H; Eklund M; Nordström T; Lantz A
    JAMA Netw Open; 2024 Apr; 7(4):e247131. PubMed ID: 38648061
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparison of skin cancer risk between renal transplant recipients and patients with glomerular diseases in rural Queensland.
    Thet Z; Lam AK; Ng SK; Aung SY; Han T; Ranganathan D; Newsham S; Borg J; Pepito C; Khoo TK
    Aust J Rural Health; 2024 Apr; 32(2):249-262. PubMed ID: 38646861
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
    Choueiri TK; Tomczak P; Park SH; Venugopal B; Ferguson T; Symeonides SN; Hajek J; Chang YH; Lee JL; Sarwar N; Haas NB; Gurney H; Sawrycki P; Mahave M; Gross-Goupil M; Zhang T; Burke JM; Doshi G; Melichar B; Kopyltsov E; Alva A; Oudard S; Topart D; Hammers H; Kitamura H; McDermott DF; Silva A; Winquist E; Cornell J; Elfiky A; Burgents JE; Perini RF; Powles T;
    N Engl J Med; 2024 Apr; 390(15):1359-1371. PubMed ID: 38631003
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Long-term outcome of pediatric renal transplantation with donors younger than 6 years.
    Ramirez-Amoros C; San Basilio M; Amesty V; Rivas S; Lobato R; Fernandez-Camblor C; Lopez-Pereira P; Martinez-Urrutia MJ
    Pediatr Transplant; 2024 May; 28(3):e14761. PubMed ID: 38628086
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 992.